BCL2 and cervical adenocarcinoma: In conclusion, this exploratory pilot study, through its robust and holistic analysis, provides evidence that MACC1, HOXC8, RARβ, BCL2, and E6/E7 could be promising molecular markers for the detection of cervical adenocarcinomas.